Can an oral glutamine supplement be given to a patient with renal dysfunction?

Glutamine Should NOT Be Given to Patients with Renal Dysfunction

Do not administer glutamine supplements to patients with renal dysfunction, particularly those who are critically ill or have kidney failure. The most recent high-quality evidence demonstrates harm with glutamine supplementation in this population.

Critical Evidence Against Glutamine Use

The 2024 ESPEN guideline provides the strongest and most definitive recommendation: In critically ill patients with acute kidney injury (AKI), AKI on chronic kidney disease (CKD), or CKD with kidney failure, additional high-dose parenteral glutamine shall NOT be administered (Grade A recommendation, 100% consensus) 1.

Why Glutamine is Contraindicated

The guideline specifically references the REDOX study, which demonstrated that high doses of glutamine (intravenous or enteral) are harmful in critically ill patients with kidney failure. This finding was corroborated by the MetaPlus trial showing similar adverse outcomes 1.

Mechanism of Harm in Renal Dysfunction

Glutamine supplementation can cause acute kidney injury through increased ammonia production and tubular toxicity 2. A 2025 case report documented AKI from tubular damage in a patient taking 18 grams daily of L-glutamine, with the proposed mechanism being increased single nephron ammonia production causing direct toxicity 2.

In patients with existing renal disease, the kidney's ability to handle glutamine is fundamentally impaired:

• Glutamine delivery is NOT rate-limiting for ammonium excretion in renal disease patients (unlike healthy subjects)
• Other factors such as surviving renal mass and intracellular enzyme activity limit ammonia synthesis
• Oral glutamine loading fails to increase urinary ammonium excretion even when plasma levels rise 3

Clinical Algorithm

For any patient with renal dysfunction:

1. If critically ill with AKI or CKD with kidney failure → Absolutely contraindicated (Grade A evidence)
2. If elderly with compromised kidney function → Avoid use; case reports show AKI risk 2
3. If stable CKD not requiring dialysis → Still not recommended; no proven benefit and potential harm from ammonia toxicity

Important Caveats

• Despite glutamine losses of approximately 1.2 g/day during continuous kidney replacement therapy, supplementation remains contraindicated 1
• Earlier small studies suggesting benefit have been superseded by large, high-quality trials showing harm
• The 2020 KDOQI nutrition guidelines do not recommend glutamine supplementation for CKD patients 4

The evidence is unequivocal: glutamine supplementation poses significant risk in renal dysfunction and should be avoided.